전체상품목록 바로가기

본문 바로가기


  • sbbn09033  
  • 현재 위치
    1. 해외도서-Npay

    Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)

    (해외배송 가능상품)
    공급사 바로가기
    기본 정보
    도서명: Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS)
    정   가: 430,000원
    판매가: 387,000원
    적립금: 7,740원 (2%)
    저   자: Eric J Strauss MD
    출판사: AAOS
    ISBN  : 9781975189860
    출판일: 2022.04
    판   형: Hardcover
    수량: 수량증가수량감소
    판   수: 71/e
    면   수: 528 page
    배송방법: 택배
    배송비: 2,500원 (30,000원 이상 구매 시 무료)
    무이자할부 안내
    구매방법

    배송주기

    개인결제창을 통한 결제 시 네이버 마일리지 적립 및 사용이 가능합니다.

    수량
    증가 감소
    상품 옵션
    옵션선택

    (최소주문수량 1개 이상 / 최대주문수량 0개 이하)

    사이즈 가이드

    수량을 선택해주세요.

    위 옵션선택 박스를 선택하시면 아래에 상품이 추가됩니다.

    상품 목록
    상품명 상품수 가격
    Instructional Course Lectures: ICL Volume 71 Print + Ebook with Multimedia(AAOS) 수량증가 수량감소 (  7740)
    총 상품금액(수량) : 0 (0개)

    할인가가 적용된 최종 결제예정금액은 주문 시 확인할 수 있습니다.

    이벤트

    상품상세정보

    의학서적전문 "성보의학서적"의 신간의학도서입니다.


    Developed in partnership with the American Academy of Orthopaedic Surgeons (AAOS) and edited by Eric J. Strauss, MD, FAAOS (editor) and Brian J. Galinat, MD, MBA, FAAOS (assistant editor), Instructional Course Lectures, Volume 71 offers solutions for the most current issues and challenges faced at all stages of your career. Filled with current, clinically relevant presentations and approaches, the book broadens your treatment options with experience-based solutions from today’s most respected surgeons and specialty experts.


    ㆍ Based on selected Instructional Course Lectures presented at the AAOS Annual Meeting 2021 in San Diego
    ㆍ Lead innovation and raise the standard of care in your operating room with new techniques and proven practical approaches.
    ㆍ Expand and refresh your general orthopaedic, specialty, and practice knowledge
    ㆍ Learn new approaches and surgical techniques from thought leaders
    ㆍ Update your action plans for rehabilitative care with expert insights
    ㆍ Review new techniques for solving the tough challenges you encounter in your practice every day
    ㆍ Chapters are abundantly illustrated with radiographs, drawings, and intraoperative photographs. Some chapters are enhanced with video that bring the techniques to life.

    - 도서목차 -


    1.    SECTION 1: Adult Reconstruction: Hip and Knee
    2.    1 Extensile Acetabular Exposure for the Direct Anterior Approach to the Hip
    3.    Introduction
    4.    Indications
    5.    Patient Positioning and Draping
    6.    Surgical Technique
    7.    Acetabular Implant Exposure
    8.    Intrapelvic Exposure
    9.    Closure
    10.    Practical Examples
    11.    Summary
    12.    References
    13.    2 Extensile Femoral Exposure for the Direct Anterior Approach to the Hip
    14.    Introduction
    15.    Indications
    16.    Patient Positioning and Draping
    17.    Surgical Technique
    18.    Incision and Subcutaneous Dissection
    19.    Extension of the Approach Distally
    20.    Femoral Releases for Improved Access of the Femur
    21.    Special Situations
    22.    Implant Removal
    23.    Trochanteric Osteotomy
    24.    Proximal Femoral Replacement
    25.    Closure
    26.    Summary
    27.    Acknowledgment
    28.    References
    29.    3 Management of Severe Acetabular Bone Loss With Chronic Pelvic Discontinuity in Revision Total Hip Arthroplasty
    30.    Introduction
    31.    Preoperative and Intraoperative Identification of a Chronic Pelvic Discontinuity
    32.    Noncemented Treatment Options for Chronic Pelvic Discontinuity
    33.    Cup-Cage Reconstruction
    34.    Custom Triflange Acetabular Implant Reconstruction
    35.    Custom 3D-Printed Acetabular Implants
    36.    Acetabular Distraction Technique With Modular Porous Metal Augments
    37.    Summary
    38.    References
    39.    4 Tough Questions in Total Hip and Total Knee Arthroplasty
    40.    Introduction
    41.    Preoperative Questions
    42.    Obesity: Is There an Absolute Cutoff?
    43.    Should Smoking Cessation Be Mandated For All Patients?
    44.    What Is the Most Accurate Predictor of Diabetic Control?
    45.    Which Patients Are Candidates for Outpatient Arthroplasty?
    46.    Perioperative Questions
    47.    When Should a First-Generation Cephalosporin for Prophylaxis Not Be Used?
    48.    Should Vancomycin Powder Be Used Topically?
    49.    Are There Any Contraindications to Tranexamic Acid in 2021?
    50.    When Should Negative-Pressure Dressings Be Used in Primary Arthroplasty?
    51.    Are Local Injections Effective?
    52.    If Bilateral Procedures Are Staged, What Is the Appropriate Interval?
    53.    Postoperative Questions
    54.    Is Formal Postoperative Physical Therapy Necessary?
    55.    When Can Patients Resume Driving After Arthroplasty?
    56.    Should Patients Be Advised Not to Return to High-Level Sporting Activity After Hip or Knee Arthroplasty?
    57.    How Long Should Patients Be Advised to Undergo Dental Prophylaxis?
    58.    Summary
    59.    References
    60.    5 Outpatient Joint Arthroplasty: Practical Guidelines for Success, Effect of COVID-19, and the Roles of Technology and Partnering With Industry
    61.    Introduction
    62.    Trends in Outpatient Joint Arthroplasty
    63.    COVID-19 and Outpatient Joint Arthroplasty
    64.    Prepandemic Ambulatory Arthroplasty Program
    65.    Postpandemic Modifications
    66.    Anesthesia Relationships and Outpatient Protocols
    67.    Anesthesia Relationships
    68.    Establishing Protocols
    69.    Barriers to Discharge
    70.    Patient/Family Choice
    71.    Pain
    72.    Nausea
    73.    Dizziness/Hypotension
    74.    Ambulation
    75.    Urinary Retention
    76.    Technology, Industry Partners, and Contracting in Outpatient Joint Arthroplasty
    77.    Technology Facilitating Discharge
    78.    Benefits of Telehealth Rehabilitation
    79.    Technology in ASCs
    80.    Partnering With Vendors/Industry
    81.    Contracting
    82.    Summary
    83.    References
    84.    6 Preoperative Optimization Before Elective Total Joint Replacement
    85.    Introduction
    86.    Weight Loss
    87.    Nutritional Assessment and Treatment
    88.    Glucose Control
    89.    Cardiac Concerns
    90.    Pulmonary Disease
    91.    Urinary Tract Infection
    92.    Lymphedema
    93.    Dental Screening
    94.    Renal Disease
    95.    Summary
    96.    References
    97.    7 Perioperative Blood Management in Total Joint Arthroplasty
    98.    Introduction
    99.    Preoperative Anemia
    100.    Background
    101.    Diagnosis and Treatment
    102.    Erythropoietin
    103.    Type and Screen
    104.    Tranexamic Acid
    105.    Aminocaproic Acid
    106.    Transfusion
    107.    Transfusion Criteria
    108.    Intraoperative Cell Salvage
    109.    Drains
    110.    Autologous Blood Donation
    111.    Leukoreduced Blood
    112.    Bleeding and Clotting Disorders; Blood-Thinning Agents
    113.    Human Immunodeficiency Virus
    114.    Summary
    115.    References
    116.    8 Often Overlooked Modifiable Risk Factors Before Total Joint Replacement
    117.    Introduction
    118.    Medications to Stop
    119.    Smoking—Nicotine (Cigarettes and Patches), Vaping, Marijuana
    120.    Alcohol Use
    121.    Substance Use Disorder
    122.    Psychiatric Disorders
    123.    Multiple Allergies
    124.    Fibromyalgia
    125.    Chronic Opioid Use
    126.    Summary
    127.    References
    128.    9 Periprosthetic Infections: Five Steps to Keep Moving Forward in 2021
    129.    Introduction
    130.    Step 1: It is Time to Include a Value Proposition in PJI Diagnosis
    131.    Step 2: It is Time for a Personalized Approach to Estimate PJI Risk and Prevent It
    132.    Step 3: PJI Treatment Requires Expertise: Patients Should Be Concentrated in Superspecialized Units
    133.    Step 4: The Success of Different Treatment Strategies Has to Be Measured With a Uniform Definition
    134.    Step 5: Benchmark Studies in Contemporary Results for One-Stage and Two-Stage Revision Are Needed
    135.    Summary
    136.    References
    137.    10 Antibiotic Prophylaxis for Total Joint Arthroplasty
    138.    Introduction
    139.    Historical Background
    140.    Goals of Prophylaxis
    141.    Overview of Current Guidelines
    142.    Choice of Prophylactic Agents
    143.    Timing and Duration of Prophylaxis
    144.    Summary
    145.    References

    146.    SECTION 2: General Orthopaedics
    147.    11 Nonsurgical Management of Osteoarthritis of the Knee: What You Should Be Injecting Now and in the Future
    148.    Introduction
    149.    Triamcinolone Acetonide Extended-Release
    150.    Hyaluronic Acid: Science, Controversy, and Current Role
    151.    The Role of Injectable Biologics: Platelet-Rich Plasma and Stem Cells
    152.    Platelet-Rich Plasma
    153.    Bone Marrow Aspirate Concentrate
    154.    Adipose-Derived SVF
    155.    Summary
    156.    References
    157.    12 Nonarthroplasty Management of Shoulder Arthritis in the Aging Athlete: Biologics and Arthroscopy
    158.    Introduction
    159.    Nonsurgical Management
    160.    Activity Modification and Pain Management
    161.    Physical Therapy
    162.    Injection Therapy With Corticosteroid or Hyaluronic Acid
    163.    Injectable Biologics (PRP, Stem Cells)
    164.    Nonarthroplasty Surgical Management of Glenohumeral Osteoarthritis
    165.    Surgical Decision Making
    166.    Shoulder Arthroscopy
    167.    Management of Focal Cartilage Defects (Microfracture)
    168.    Glenoid Resurfacing (Experimental)
    169.    Autologous Chondrocyte Implantation and Fresh OCA Transplantation
    170.    Summary
    171.    References

    172.    SECTION 3: Hand and Wrist
    173.    13 Managing Challenges in Thumb Carpometacarpal Arthritis
    174.    Introduction
    175.    Radiographic Classification
    176.    Anatomy and Pathoanatomy
    177.    Laxity, Proprioception, and Functional Demands
    178.    Trapezium-Sparing Procedures
    179.    Extension Osteotomy
    180.    Arthrodesis
    181.    Tenotomy, Fat Interposition, Synovectomy, and Denervation
    182.    Nonimplant Trapezial Resection Procedures
    183.    Trapeziectomy Alone
    184.    Distraction Hematoma Arthroplasty
    185.    Interposition Arthroplasty
    186.    Ligament Reconstruction With or Without Interposition
    187.    Arthroscopy
    188.    Implant Arthroplasty Procedures
    189.    Interposition
    190.    Hemiarthroplasty/Total Joint Arthroplasty
    191.    Indications and Contraindications
    192.    Technical Considerations
    193.    Outcomes
    194.    Literature Review
    195.    Management of Early-Stage (I and II) Thumb CMC Arthritis
    196.    Management of Moderate-Stage (II and III) Thumb CMC Arthritis
    197.    Management of Severe Stage (IV) Thumb CMC Arthritis
    198.    Summary
    199.    References
    200.    14 Tips and Tricks in the Management of Distal Radius Fractures
    201.    Introduction
    202.    Distal Radius Volar Plating
    203.    Challenge 1: Choosing the Right Indication
    204.    Challenge 2: The Unstable Radial Column
    205.    Challenge 3: The Comminuted Lunate Fossa
    206.    Challenge 4: The Volar Marginal Fragment
    207.    Challenge 5: The Inveterate Fracture
    208.    Challenge 6: Central Articular Impaction
    209.    Challenge 7: Radial Shift
    210.    Challenge 8: Plate Selection
    211.    Challenge 9: The Unstable DRUJ
    212.    External Fixation
    213.    Nonsurgical Management
    214.    Surgical Management
    215.    The Importance of Wrist Position for Digital Function
    216.    Recommended Technique
    217.    Further Comparison With Open Reduction and Internal Fixation
    218.    The Things That Should be Remembered But are Forgotten: The Management of Concomitant and Associated Injuries With Distal Radius Fractures
    219.    Scapholunate Ligament Injuries
    220.    DRUJ Instability and TFCC Pathology
    221.    EPL Rupture
    222.    Summary
    223.    References

    224.    SECTION 4: Musculoskeletal Oncology
    225.    15 Evolution of Surgical Management of Metastatic Disease of the Pelvis
    226.    Introduction
    227.    Patient Assessment
    228.    History of Pelvic Surgery
    229.    Anatomic Location and Classification Systems
    230.    Indications
    231.    Imaging
    232.    Preoperative Planning
    233.    Harrington Reconstruction Method
    234.    Minimally Invasive Options
    235.    Cryotherapy
    236.    Radiofrequency Ablation
    237.    Microwave Ablation
    238.    MRI-Guided High-Intensity Focused Ultrasound Ablation
    239.    Acetabuloplasty/Percutaneous Cementoplasty
    240.    Harrington 0 to I or MAC 1
    241.    Harrington II or MAC 2
    242.    Harrington III or MAC 3
    243.    Harrington IV or MAC 4
    244.    Custom Prosthesis
    245.    Summary
    246.    References
    247.    16 Local Control of Cancers With Various Ablation Techniques
    248.    Introduction
    249.    Patient Selection
    250.    Imaging Options and Considerations
    251.    Ablative Modalities
    252.    Soft-Tissue Disease
    253.    Procedural Workflow
    254.    Patient Positioning
    255.    Cone-Beam CT Scan
    256.    Ablation
    257.    Cementation
    258.    Postoperative Course
    259.    Complications
    260.    Case Examples
    261.    Case 1
    262.    Case 2
    263.    Case 3
    264.    Case 4
    265.    Case 5
    266.    Discussion
    267.    Future Directions
    268.    Summary
    269.    References
    270.    17 Ablation, Osteoplasty, Reinforcement, and Internal Fixation as a New Alternative First-Line Management for Osteolytic Pelvic Metastases
    271.    Introduction
    272.    Rationale for AORIF
    273.    Oncologic Considerations
    274.    Biomechanical Considerations
    275.    Biologic Considerations
    276.    Pain Control Perspectives
    277.    Early Ambulation and Muscle Strengthening
    278.    Indications
    279.    Approach
    280.    Imaging
    281.    Ablation
    282.    Balloon Osteoplasty
    283.    PMMA Bone Cementoplasty
    284.    Internal Fixation
    285.    Limitations of AORIF and Other Percutaneous Procedures
    286.    Summary
    287.    References
    288.    18 Fluoroscopic Percutaneous Fixation of Periacetabular Metastatic Cancer: The Tripod Technique
    289.    Introduction
    290.    Indications
    291.    Preoperative Preparations
    292.    Surgical Techniques
    293.    Positioning
    294.    General Surgical Procedure
    295.    Anterior Column Screw
    296.    Posterior Column Screw
    297.    Transcolumnar Screw
    298.    Conversion to THA
    299.    Modification of the Tripod Construct
    300.    Adaptation to Manage Non-periacetabular Lesions
    301.    Tips and Tricks
    302.    Postoperative Care
    303.    Discussion
    304.    Summary
    305.    References
    306.    19 Tumors and Tumorlike Conditions of Which Every Orthopaedic Surgeon Should Be Aware
    307.    Introduction
    308.    The General Orthopaedic and Trauma Practices
    309.    Workup
    310.    Surgical Principles
    311.    Trauma and Musculoskeletal Oncology
    312.    Orthopaedic Oncology in the Setting of Pediatrics
    313.    Benign Pediatric Bone Tumors
    314.    Benign-Aggressive and Malignant Pediatric Bone Tumors
    315.    The Sports and Arthroplasty Practices
    316.    Clinical Presentation
    317.    Enchondroma
    318.    Baker Cyst
    319.    Enostosis
    320.    Synovial Chondromatosis
    321.    Tenosynovial Giant Cell Tumor
    322.    Osteolysis
    323.    Pseudotumor
    324.    Osteonecrosis
    325.    Multiple Hereditary Exostoses
    326.    Paget Disease
    327.    Sarcoma
    328.    The Spine Practice: Staying Out of Trouble With Tumors
    329.    General Approach to Spine Tumors
    330.    Spine Tumor Mimics
    331.    Benign, Quiescent Conditions
    332.    Metastatic Spinal Disease
    333.    Primary Spinal Malignancies
    334.    Summary
    335.    References

    336.    SECTION 5: Pediatrics
    337.    20 Lower Limb Deformity Correction: Analysis and Preoperative Planning
    338.    Introduction
    339.    Deformity Analysis of the Lower Extremity
    340.    Preoperative Planning: Hexapod External Fixation
    341.    Case Presentation
    342.    Preoperative Planning: Plate Fixation
    343.    Case Presentation
    344.    Preoperative Planning: Intramedullary Nail Fixation
    345.    Case Presentation
    346.    Pearls and Pitfalls
    347.    Additional Considerations
    348.    Summary
    349.    References
    350.    21 Limb Reconstruction After Premature Growth Arrest Secondary to Bone Infections
    351.    Introduction
    352.    Risk Factors for Sequelae
    353.    Delayed Diagnosis
    354.    Wrong or Insufficient Treatment
    355.    Newborns
    356.    Infection Caused by Panton-Valentine Leukocidin S aureus
    357.    Pathophysiology of Sequelae
    358.    Evaluation of a Physeal Bar
    359.    Predicting LLD
    360.    Treatment Strategies
    361.    Regenerative Therapies
    362.    Physeal Preservation Techniques
    363.    Physeal Distraction
    364.    Management of Sequelae
    365.    Summary
    366.    References

    367.    SECTION 6: Trauma
    368.    22 Do All Fractures Need Surgery?
    369.    Introduction
    370.    Ankle Fractures
    371.    Treatment Principles
    372.    Isolated Malleolar Fractures
    373.    Isolated Lateral Malleolus Fractures
    374.    Bimalleolar and Trimalleolar Fractures
    375.    Proximal Humerus Fractures in Patients Older Than 60 Years
    376.    Treatment Principles
    377.    Nonsurgical Treatment Outcomes
    378.    Surgical Treatment: Is It Too Aggressive?
    379.    Trends and Proposed Treatment Algorithm
    380.    Humeral Shaft Fractures in Young, Active Patients
    381.    Treatment Principles
    382.    Nonsurgical Treatment
    383.    Comparative Results and Outcomes
    384.    Distal Radius Fractures in the Elderly
    385.    Treatment Principles
    386.    Trends
    387.    Is Treatment Too Aggressive?
    388.    Limitations
    389.    Key Takeaways
    390.    Summary
    391.    References
    392.    23 Forearm Fractures: Diagnosis and Contemporary Treatment Strategies
    393.    Introduction
    394.    Epidemiology
    395.    Assessment
    396.    Initial Management
    397.    Principles of Treatment
    398.    Classification of Diaphyseal Forearm Fractures
    399.    Radial Shaft Fractures
    400.    Management
    401.    Outcomes
    402.    Ulnar Shaft Fractures
    403.    Management
    404.    Outcomes
    405.    Both-Bone Forearm Fractures
    406.    Initial Assessment
    407.    Management
    408.    Outcomes
    409.    Galeazzi Injuries
    410.    Classification System
    411.    Management
    412.    Outcomes
    413.    Monteggia Fracture-Dislocations
    414.    Classification
    415.    Management
    416.    Outcomes
    417.    Summary
    418.    References
    419.    24 Elbow Trauma: An Evidence-Based Approach to Improving Outcomes
    420.    Introduction
    421.    DHFs: Evidence-Based Management
    422.    Radial Head/Neck Fractures: When and How to Fix or Replace
    423.    Olecranon Fractures: An Approach for Injuries From Simple to Extreme
    424.    Terrible Triad Injuries: How to Improve Outcomes
    425.    Coronoid Fractures: When and How to Fix Them
    426.    Elbow Dislocations: Tips and Tricks to Improve Outcomes
    427.    Managing Complications in Elbow Fracture Surgery
    428.    Monteggia Injury
    429.    Ulnar Neuropathy
    430.    Stiffness
    431.    Nonunion
    432.    Summary
    433.    References
    434.    25 Augmentation of Fracture Repair: Is Anything Ready for Prime Time?
    435.    Introduction
    436.    Universal Use of Antibiotic Powder in Open Wounds: Do the Benefits Outweigh the Risks?
    437.    RIA for Autograft: Should This Be Always Used or Is There Still a Role for the Iliac Crest?
    438.    What Role Does Allograft Play in Fracture Management?
    439.    Cell-Based Therapies for Fracture Repair: Is the Evidence Strong Enough for Routine Use?
    440.    Is There Any Role for BMPs and Osteoinductive Proteins?
    441.    An Evidence-Based Approach to the Management of Nonunion With No Bone Defect
    442.    An Evidence-Based Approach to the Management of Nonunion With a Bone Defect
    443.    Summary
    444.    References

    445.    SECTION 7: Shoulder and Elbow
    446.    26 Shoulder Arthroplasty in the Aging Athlete: Considerations in the Younger Patient
    447.    Introduction
    448.    General Considerations
    449.    Patient Evaluation
    450.    Diagnoses
    451.    Hemiarthroplasty
    452.    Hemiarthroplasty With Ream and Run
    453.    Hemiarthroplasty With Biologic Resurfacing
    454.    Stemless Total Shoulder Arthroplasty
    455.    Resurfacing Prosthesis
    456.    Partial Resurfacing Prosthesis
    457.    Anatomic Total Shoulder Arthroplasty
    458.    Reverse Total Shoulder Arthroplasty
    459.    Postoperative Rehabilitation Protocol
    460.    Summary
    461.    References
    462.    27 New Approaches to the Diagnosis and Management of Periprosthetic Joint Infection of the Shoulder
    463.    Introduction
    464.    Evaluation of PJI of the Shoulder: Development of a New Diagnostic Criteria and Its Application
    465.    Diagnostic Testing
    466.    Definition of Shoulder PJI
    467.    Cutibacterium and the Failed Shoulder Arthroplasty
    468.    Treatment Strategies for PJI of the Shoulder: Antibiotics, One-Stage Versus Two-Stage Revision, and What to Do With Delayed, Unexpected Positive Cultures
    469.    Prevention
    470.    Antibiotics Alone
    471.    Irrigation and Débridement With Implant Retention
    472.    One-Stage and Two-Stage Revision Arthroplasty
    473.    Permanent Antibiotic Spacer
    474.    Resection Arthroplasty
    475.    Unexpected Positive Cultures
    476.    Reconstructive Options for PJI of the Shoulder
    477.    Glenoid Bony Defects
    478.    Humeral Bony Defects
    479.    Summary
    480.    References
    481.    28 Stemless Shoulder Arthroplasty
    482.    Introduction
    483.    Stemless Humeral Implants in Anatomic TSA
    484.    Stemless Humeral Implants in Reverse TSA
    485.    Summary
    486.    References

    487.    SECTION 8: Spine
    488.    29 Is It the Back or the Hip? Differentiating Lumbar Spine From Hip Pathologies: Key Points of Evaluation and Treatment
    489.    Introduction
    490.    The Incidence and Likely Etiology of Concurrent Hip and Spine Pathology
    491.    Clinical Presentation
    492.    History
    493.    Physical Examination
    494.    Differential Diagnosis
    495.    Imaging and Radiologic Workup
    496.    Nonsurgical Management
    497.    Surgical Intervention
    498.    Outcomes Following Surgery for Patients With HSS
    499.    Summary
    500.    References
    501.    30 Navigation Options for Spinal Surgeons: State of the Art 2021
    502.    Introduction
    503.    3D Image-Based CAN
    504.    Robot-Assisted Navigation
    505.    3D-Printed Patient-Specific Drill Guides
    506.    Radiation Considerations
    507.    Radiation From CT and Enabling Technologies
    508.    Intraoperative CT-Guided Navigation Compared With Fluoroscopy
    509.    Operating Room Personnel Exposure
    510.    Effect of Navigation on Education for Trainees
    511.    Safety and Economic Considerations With Navigation
    512.    Summary
    513.    References
    514.    31 Vertebral Body Tethering: Rationale, Results, and Revision
    515.    Introduction
    516.    Indications and Patient Selection
    517.    Surgical Approach and Thoracoscopic Technique Considerations
    518.    Anesthesia and Positioning
    519.    Thoracoscopic Approach
    520.    Minithoracotomy With Thoracoscopic Assistance
    521.    Approach for Thoracolumbar/Lumbar Curves
    522.    Perioperative Care
    523.    Clinical Outcomes
    524.    Complications
    525.    Future Directions
    526.    Summary
    527.    References
    528.    32 Achieving Lumbar Fusion: An Evidence-Based Approach to Selecting Technique, Implants, and Biologics
    529.    Introduction
    530.    Approach to Achieving Fusion: Which Technique Is the Best?
    531.    Interbody Cages: Which Material Is the Best?
    532.    Bone Graft Choices: Autograft, Allograft, and Bone Graft Extenders
    533.    Bone Morphogenetic Protein
    534.    Cellular-Based Allografts
    535.    Osteoporosis in Spine Surgery
    536.    Summary
    537.    References
    538.    33 Update on the Diagnosis and Management of Spinal Infections
    539.    Introduction
    540.    Etiopathogenesis
    541.    Clinical Presentation
    542.    Laboratory Evaluation
    543.    Imaging Studies
    544.    Treatment
    545.    Nonsurgical Treatment
    546.    Surgical Treatment
    547.    Epidural Abscess
    548.    Prognosis
    549.    Summary
    550.    References

    551.    SECTION 9: Foot and Ankle
    552.    34 Chronic Achilles Tendon Ruptures: From Bracing Treatment to Complex Reconstruction
    553.    Introduction
    554.    Clinical Presentation
    555.    Imaging
    556.    Nonsurgical Treatment
    557.    Muscle and Tendon Structure and Function
    558.    Treatment Options
    559.    Management of Chronic Achilles Tendon Ruptures With Local Tissue Procedures
    560.    Achilles Tendon Repair Using Native Achilles Tissue
    561.    Management of Chronic Achilles Tendon Ruptures Using Graft Reconstruction
    562.    Allograft Reconstruction for Chronic Achilles Tendon Ruptures
    563.    Management of Chronic Achilles Tendon Ruptures Using Tendon Transfers
    564.    Summary
    565.    References\

    566.    SECTION 10: Sports Medicine
    567.    35 Surgical Considerations in Revision Anterior Cruciate Ligament Reconstruction
    568.    Introduction
    569.    Epidemiology
    570.    Preoperative Evaluation
    571.    Etiology
    572.    Tunnel Placement
    573.    Concomitant Ligamentous Laxity
    574.    Concomitant Meniscal Pathology
    575.    Malalignment
    576.    Indications and Patient Selection
    577.    Surgical Considerations
    578.    Staging
    579.    Tunnel Placement
    580.    Graft Choice
    581.    Anterolateral Ligament Reconstruction or LET
    582.    Postoperative Rehabilitation
    583.    Outcomes
    584.    Summary
    585.    References
    586.    36 Postoperative Infection After Anterior Cruciate Ligament Reconstruction: Prevention and Management
    587.    Introduction
    588.    Infection Prevention Strategies
    589.    Tobacco Cessation
    590.    Prophylactic Intravenous Antibiotics
    591.    Drain Use
    592.    Graft Choice
    593.    Clinical Pathways
    594.    Gentamicin Irrigation/Graft Presoaking
    595.    Vancomycin Graft Presoaking
    596.    Management of ACL Infection
    597.    Diagnosis
    598.    Arthroscopic Irrigation
    599.    The Importance of Graft Retention
    600.    Authors’ Experience
    601.    Summary
    602.    References
    603.    Index



    기타 의학도서에  관련된 문의사항은 고객센터(02-854-2738) 또는 저희 성보의학서적 홈페이지내 도서문의 게시판에 문의바랍니다.
    감사합니다.
    성보의학서적 "http://www.medcore.kr

    상품결제정보

    고액결제의 경우 안전을 위해 카드사에서 확인전화를 드릴 수도 있습니다.

    확인과정에서 도난 카드의 사용이나 타인 명의의 주문등 정상적인 주문이 아니라고 판단될 경우 임의로 주문을 보류 또는 취소할 수 있습니다.  

    무통장 입금은 상품 구매 대금은 PC뱅킹, 인터넷뱅킹, 텔레뱅킹 혹은 가까운 은행에서 직접 입금하시면 됩니다.  
    주문시 입력한 입금자명과 실제입금자의 성명이 반드시 일치하여야 하며, 3일 이내로 입금을 하셔야 하며 입금되지 않은 주문은 자동취소 됩니다.

    배송정보

    • 배송 방법 : 택배
    • 배송 지역 : 전국지역
    • 배송 비용 : 2,500원
    • 배송 기간 : 3일 ~ 5일
    • 배송 안내 :


    • 고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다

      - 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
      (단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
      - 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
      - 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
      - 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
      - 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
      - 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
      상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
      - 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.


      해외원서의 경우
      - 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
      이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
      - 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
      다시 한번 국내재고를 확인해 드립니다.

      - 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
      - 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
      이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

    교환 및 반품정보

    반품안내
    전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.

    반품가능기간
    - 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)


    - 주문하신 것과 다른 상품을 받으신 경우

    - 파본인 상품을 받으신 경우
    - 배송과정에서 손상된 상품을 받으신 경우



    - 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)

    - 탐독의 흔적이 있는 경우
    - 소비자의 실수로 상품이 훼손된 경우
    - 고객님의 주문으로 수입된 해외 도서인 경우
    - 수령일로 14일 지난 상품의 경우

    - 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
    - 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
      이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.


    반품절차
    - 배송완료후 3일 이내에 고객센터 02-854-2738 혹은 1:1 문의게시판을 통해 교환 및 반품 의사를 알려주세요.
    - 도서는 택배 또는 등기우편으로 보내주시기 바랍니다.
    - 14일 이내에 교환/반품/환불 받으실 상품이 회수되어야 하며, 반품과 환불의 경우 상품주문시 면제받으셨던
      배송비와 반품배송비까지 고객님께서 부담하시게 됩니다.

    반품주소
    (10881) 서울시 구로구 구로중앙로26길 32(구로동) 1층(성보의학서적)
    전화) 02-854-2738

    환불방법
    - 대금은 반품 확인 후에, 카드취소/ 적립금 지급/ 계좌로 환불조치 해 드립니다.
    - 카드결제 시 카드 승인취소절차를 밟게 되며 무통장입금시 현금 환불 혹은 적립금으로 변환 가능합니다.
    - 반품도서와 함께 도서명, 주문번호와 환불계좌번호를 알려주시면 빠른 처리 가능합니다.



    서비스문의

    성보의학서적(Medical Book Store) 전화: 02) 854-2738 팩스: 02) 854-2808 이메일: medcore15@naver.com

    고객센터: (02)854-2738

    상품사용후기

    상품의 사용후기를 적어주세요.

    게시물이 없습니다

    상품문의하기 모두 보기

    상품 Q&A

    상품에 대해 궁금한 점을 해결해 드립니다.

    게시물이 없습니다

    상품문의하기 모두 보기

  • sbbn09036  


  • 장바구니 0

    맨위로

    마이쇼핑 게시판 배송조회 blog